甲状腺癌
- 名Thyroid cancer;carcinoma of thyroid
-
~(131)碘消除甲状腺癌术后残留甲状腺组织
Iodine-131 Ablation of the Thyroid Remnants after Surgical Removal of Carcinoma of Thyroid
-
对41例伴有淋巴结或血行转移的隐匿性甲状腺癌进行回顾性临床分析。
The clinical material of 41 cases with the occult carcinoma of thyroid was analysed retrospectively .
-
人甲状腺癌组织中蛋白激酶C和蛋白激酶A活性变化的实验研究
Study of Change of PKC Activity and PKA Activity in Human Thyroid Cancer
-
54例甲状腺癌的CT研究
CT Findings of Thyroid Cancer : Preliminary Analyses in 54 Cases
-
甲状腺癌的CT诊断
CT diagnosis of thyroid carcinoma
-
甲状腺癌差异表达cDNA消减文库的构建
Construction of differential expression cDNA subtractive library in thyroid carcinoma tissue
-
甲状腺癌bcl-2蛋白及bcl-2mRNA表达的研究
Expression of bcl 2 Protein and bcl 2 mRNA in Thyroid Carcinoma
-
甲状腺癌中CD(44)V6和基质金属蛋白酶-2的表达
Expression of CD_ ( 44 ) V6 and MMP-2 in human thyroid carcinoma
-
Survivin在分化型甲状腺癌组织中的表达及其与肿瘤微血管形成的关系
Expression of Survivin and its correlation with tumor angiogenesis in differentiated thyroid carcinomas
-
47例甲状腺癌中FasL检测的病理学意义
Pathological significance of investigating FasL in 47 cases of thyroid adenocarcinoma
-
Bcl-2,Caspase-3在甲状腺癌和桥本甲状腺炎中的表达及意义
Expressions of Bcl-2 , Caspase-3 and their effects on thyroid carcinoma and Hashimoto 's thyroiditis
-
目的:甲状腺癌(thyroidcarcinoma)是最常见的甲状腺恶性肿瘤,约占全身恶性肿瘤的1%。
Objectives : The thyroid carcinoma which accounting for about 1 % of systemic malignancy is the most common malignant tumor of thyroid .
-
目的:双侧甲状腺癌(bilateralthyroidcarcinoma)是一种特殊类型的甲状腺恶性肿瘤,其中大部分为甲状腺乳头状癌。
Objective : Bilateral thyroid carcinoma is a special type of thyroid carcinoma , most of which belongs to papillary thyroid carcinoma .
-
应用RT-PCR技术检测人类甲状腺癌中ret癌基因活化的研究
Detection of ret oncogen activation in human thyroid carcinomas by RT PCR
-
目的探讨影响分化型甲状腺癌(differentiatedthyroidcarcinoma,DTC)预后的因素。
[ Objective ] To investigate the factors that influence the prognosis of differentiated thyroid carcinoma ( DTC ) .
-
分化型甲状腺癌~(18)F-FDGPET显像的临床应用
Application of ~ ( 18 ) F-FDG PET scan in patients with differentiated thyroid cancer
-
甲状腺癌血清中SIL-2R升高与甲状腺癌的病理类型无明显关系;
There was no significant difference between thyroid carcinoma and pathological ;
-
基质金属蛋白酶-9和原癌基因c-myc在甲状腺癌中的表达及其关系探讨
Expression of matrix metalloproteinase 9 ( MMP-9 ) and c-myc genes in thyroid carcinoma
-
临床颈淋巴结阴性患者,术中快速切片(FS)一经确诊分化型甲状腺癌,应常规行中央区淋巴结清扫术。
The clearance of lymph nodes in central area is needed for differentiated thyroid cancer .
-
甲状腺癌p53调节基因Mdm2以及p21~(WAF/CIP1)蛋白的表达
Expression of proteins in p53 ( Mdm2-p53-p21 ~ ( WAF / CIP1 )) pathway in thyroid carcinoma
-
突破周围的基底膜,进人ECM是甲状腺癌发生转移和侵袭的第一步。
Break through the basement membrane around into the ECM is the first step in thyroid cancer metastasis and invasion .
-
在甲状腺癌、肺癌和结肠癌中ER有强表达,而PR表达较弱。
ER expression was high in tumor cells of the thyroid gland , lung and colon , while PR expression was low or negative .
-
PCNA表达与甲状腺癌的病理类型、TNM分期和术后生存期密切相关(P<0.01)。
The expression of PCNA protein was close related with thyroid carcinomatous pathological type , TNM stage and postoperative survival time ( P 0.01 ) .
-
甲状腺癌中Ki67和survivin的表达及意义
Expressions of Ki-67 and survivin in thyroid cancer and their significance
-
目的报道2例卵巢原发性乳头状甲状腺癌(PTC),分析其临床病理特征。
Objective To report 2 cases of ovarian primary papillary thyroid carcinoma ( PTC ), and to discuss its clinicopathologic features .
-
结论ASODN可通过特异性封闭甲状腺癌细胞VEGF表达,抑制内皮细胞生长,干扰肿瘤血管生成。
Conclusion ASODN can suppress endothelial cell growth and inhibit tumor angiogenesis possibly by specifically blocking VEGF expression in thyroid carcinoma .
-
目的观察人类甲状腺癌中ret癌基因的活化及其意义。
Objective : To investigate the frequency and significance of ret oncogene activation in human thyroid carcinomas .
-
目的检测甲状腺癌中ER、PR的表达,并且探讨它们的表达与肿瘤浸润转移的关系。
To study the relations between the expressions of the estrogen receptor ( ER ), progesterone receptor ( PR ) and tumor infiltration and metastasis in thyroid carcinoma .
-
杆状病毒介导NIS基因放射治疗甲状腺癌的实验研究
Experimental study of baculovirus-mediated transfer of the thyroid sodium / iodide symporter gene into thyroid cancer for targeted radiotherapy
-
甲状腺癌组织中H-ras基因突变及蛋白表达的预后价值
Significance of Mutations and Protein Expression of H ras in Human Thyroid Carcinoma